PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

NEXT STORY
Generex Signs Binding Licensing & Research Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia
PREV STORY
HalioDx contribution to precision medicine at ESMO 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies

MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

author_avatar
NASDAQ Market News

Caladrius Biosciences Doses First Patient with CLBS12 in Phase 2 Critical Limb Ischemia Trial in Japan

BASKING RIDGE, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” ...

author_avatar
NASDAQ Market News

InSync to Showcase Cloud-Based Solutions & Services at MGMA 2016 Annual Conference

TAMPA, Fla., Oct. 24, 2016 (GLOBE NEWSWIRE) -- InSync Healthcare Solutions, a leading provider ...

author_avatar
NASDAQ Market News